Why AbbVie May Have Overpaid for Cancer Drug Maker. Mergers, Acquisitions and Divestitures, Drugs (Pharmaceuticals), Biotechnology and Bioengineering, Pharmacyclics, Incorporated, AbbVie Inc, Johnson & Johnson, Shire PLC